drugset
Drugs / GPO-VIR S
last change Apr 2011 re-read 2 minutes ago

GPO-VIR S

Developed for
HIV infectious disease
Investigated by
Queen Savang Vadhana Memorial Hospital, Thailand · SEARCH Research Foundation · Thai Red Cross AIDS Research Centre · University of Hawaii

Trials 1 · a red edge is where a trial was stopped

today NCT00669487 · Ph 3
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00669487 Apr 2008 → Dec 2010 HIV infectious disease SEARCH Research Foundation Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GPO-VIR S “GPO-VIR S(D4T30mg+3TC150mg+NVP200mg)1 pill orally every 12 hours until week 24 and then switch to GPO-VIR Z” NCT00669487 ↗
Route Oral “GPO-VIR S(D4T30mg+3TC150mg+NVP200mg)1 pill orally every 12 hours until week 24 and then switch to GPO-VIR Z” NCT00669487 ↗